Latest News
- Min. Nadda Unveils ?13,000-Crore Bio-Pharma SHAKTI and Chemical Parks Push to Expand India’s Global Chemicals and Biologics Footprint
- Aurobindo Pharma Subsidiary Launches Generic Cancer Drug in US, Expands Oncology Portfolio in Global Generics Market
- KIMS Hospitals Introduces Adaptive Deep Brain Stimulation in India for Advanced Parkinson’s Treatment
Akums Drugs & Pharmaceuticals expands into the gummies segment
The gummies have been creatively formulated and designed so that children can take their nutrition with ease.
- By Newsdesk
- New Delhi
- Mar 04, 2023
Akums Drugs & Pharmaceuticals announced on Thursday that it has entered the gummies market by establishing a new manufacturing plant. The company stated that it aims to cater to a variety of conditions for adults, children, and the elderly who are looking for an alternative to traditional dosage forms such as tablets, capsules, syrup, and so on, but no longer find these options palatable or convenient.
The gummy products are tailored to meet general wellness and nutritional needs, with options ranging from multivitamins for children, immunity boosters to those that support hair health, PMS balance, urinary health, morning sickness, and sleep, among other things.
"We are always committed to ensuring that we not only produce effective medicines, but also produce them in easily consumable formats. That is what we hope to accomplish with this segment "Sandeep Jain, Akums' Joint Managing Director, mentioned in a statement.
This year, Akums aims to expand its R&D and manufacturing facilities in order to introduce next-generation gummies that will meet the diverse needs of consumers. Between 2021 and 2028, the global gummies market is expected to grow at a CAGR of 7.3%.